Lin Ji
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 2%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- RNA modifications and cancer 20
- RNA Interference and Gene Delivery 16
- Circular RNAs in diseases 9
- Ubiquitin and proteasome pathways 8
- Genetics 24
- Virus-based gene therapy research 18
- Co-authors
- Jack A. Roth (60 shared papers)John D. Minna (20 shared papers)Bingliang Fang (24 shared papers)Xiujun Cai (14 shared papers)Kai Xu (19 shared papers)Xiao Liang (9 shared papers)Junjie Xu (8 shared papers)Zhe Wan (7 shared papers)
- Journals
- Cancer Research (15 papers)Oncogene (5 papers)PLoS ONE (5 papers)Scientific Reports (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Lin Ji
139 papers receiving 5.3k citations
Lin Ji's Hit Papers
Peers
Comparison fields: 5 of 139
- Cancer Research 1.3k
- Molecular Biology 3.3k
- Oncology 899
- Biotechnology 246
- Genetics 669
Countries citing papers authored by Lin Ji
This map shows the geographic impact of Lin Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Ji more than expected).
Fields of papers citing papers by Lin Ji
This network shows the impact of papers produced by Lin Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Ji. The network helps show where Lin Ji may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Ji, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 148 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CircRNA-SORE mediates sorafenib resistance in hepatocellular carcinoma by stabilizing YBX1 Hit paper breakdown → | 2020 | 343 |
| 2 | 2012 | 245 | |
| 3 | 2020 | 223 | |
| 4 | 2011 | 220 | |
| 5 | 2009 | 199 | |
| 6 | 2001 | 172 | |
| 7 | 2012 | 161 | |
| 8 | Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. | 2002 | 155 |
| 9 | 2016 | 132 | |
| 10 | 2015 | 130 | |
| 11 | 2018 | 122 | |
| 12 | 2008 | 117 | |
| 13 | 2004 | 102 | |
| 14 | 2021 | 97 | |
| 15 | 2018 | 85 | |
| 16 | 2011 | 85 | |
| 17 | 2005 | 81 | |
| 18 | 2004 | 81 | |
| 19 | 2001 | 81 | |
| 20 | Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. | 2001 | 79 |
About Lin Ji
Lin Ji is a scholar working on Molecular Biology, Genetics, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 148 papers that have together received 5.4k indexed citations. Recurring topics across this work include RNA modifications and cancer (20 papers), Virus-based gene therapy research (18 papers), RNA Interference and Gene Delivery (16 papers), MicroRNA in disease regulation (13 papers), Cancer Research and Treatments (11 papers), Circular RNAs in diseases (9 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer-related molecular mechanisms research (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (3.3k citations), Oncology (899 citations), Biotechnology (246 citations) and Genetics (669 citations). Lin Ji has collaborated with scholars based in United States, China and France. Frequent co-authors include Jack A. Roth, John D. Minna, Bingliang Fang, Xiujun Cai, Kai Xu, Xiao Liang, Junjie Xu, Zhe Wan, Ignacio I. Wistuba and E. Neely Atkinson. Their work appears in journals such as Cancer Research, Oncogene, PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.